Stock Price Targets and Analyst Ratings

Stay on top of the latest U.S. and international stock analyst recommendations with our up-to-date list of stock price targets and analyst ratings. This page tracks newly issued analyst ratings, price targets, upgrades, downgrades, and other broker actions to help you see how Wall Street analysts view the companies you follow. Use these ratings to compare sentiment, spot shifts in outlook, and make more informed investment decisions.

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAMI Acadian Asset Management	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kenneth S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$70.89 +4.1%	$66.00	Sector Perform
ADI Analog Devices	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$398.05 -3.9%	$405.00
ADI Analog Devices	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$398.05 -3.9%		Buy
AMCR Amcor	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gabe Hajde Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.14 +3.9%	$43.00 ➝ $41.00	Equal Weight
AMGN Amgen	Target Lowered by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$331.57 +0.2%	$400.00 ➝ $375.00	Buy
AML Aston Martin Lagonda Global	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 43.38 -3.6%	GBX 50 ➝ GBX 50	Hold
AMRX Amneal Pharmaceuticals	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glen Santangelo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.23 +3.6%	$15.00 ➝ $16.00	Overweight
AMZN Amazon.com	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$265.01 +2.2%	$313.00 ➝ $312.00	Overweight
ANDE Andersons	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$70.65 +1.0%	$90.00
ANIOY Acerinox	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.38		Buy
Trump's gold order: the announcement they won't put on the front page (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now
ANTA Antalpha Platform	Target Lowered by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hal Goetsch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.43 -0.8%	$10.00 ➝ $9.50	Buy
APA APA	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Brackett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.32 -3.9%	$37.00 ➝ $40.00	Market Perform
APA APA	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.32 -3.9%	$40.00 ➝ $44.00	Neutral
APEMY Aperam	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.00		Neutral
ARBB Arbuthnot Banking Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 840 +1.2%		House Stock
AS Amer Sports	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Komp Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.84 +3.0%	$51.00
AS Amer Sports	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$34.84 +3.0%	$52.00
AS Amer Sports	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.84 +3.0%	$60.00 ➝ $62.00	Buy
ASML ASML	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,550.13 +6.2%		Buy
AVAH Aveanna Healthcare	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.68 +0.7%	$8.00 ➝ $9.00	Hold
BAER Bridger Aerospace Group	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.95 +16.8%	$4.50	Buy
BALY Bally's	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.84 +1.5%	$8.00	Underweight
BBWI Bath & Body Works	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.89 +4.8%		Neutral
BBWI Bath & Body Works	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.89 +4.8%	$22.00 ➝ $19.00	Neutral
BEKE KE	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.08 -3.4%		Overweight
BETA BETA Technologies	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andre Madrid Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.94 +2.3%	$40.00 ➝ $33.00	Buy
BIDU Baidu	Target Raised by	Nomura Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$135.22 -1.8%	$186.00 ➝ $190.00	Buy
BIDU Baidu	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shyam Patil Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$135.22 -1.8%	$120.00 ➝ $140.00	Neutral
BILI Bilibili	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.30 -8.5%		Buy
BIP Brookfield Infrastructure Partners	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Kad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.20 +2.0%	$45.00 ➝ $46.00	Overweight
BIPC Brookfield Infrastructure	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Kad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.49 +1.4%	$45.00 ➝ $46.00	Underweight
BJ BJ's Wholesale Club	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$95.25 -2.5%	$110.00	Neutral
BLDP Ballard Power Systems	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biju Perincheril Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.76 +13.9%	$2.60 ➝ $4.25	Neutral
BLND British Land	Reiterated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 387.20 +2.4%	GBX 410 ➝ GBX 410	Hold
BLND British Land	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 387.20 +2.4%	GBX 531 ➝ GBX 531	Buy
BMO Bank of Montreal	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$216.82 +2.3%	C$195.00 ➝ C$196.00
BMO Bank of Montreal	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$216.82 +2.3%	C$224.00 ➝ C$230.00	Buy
BMY Bloomsbury Publishing	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 617.05 +2.5%	GBX 825 ➝ GBX 825	Buy
BNS Bank of Nova Scotia	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$108.50 +2.0%	C$110.00 ➝ C$108.00	Hold
BNS Bank of Nova Scotia	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$108.50 +2.0%	C$104.00 ➝ C$105.00
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now.
BNTGY Brenntag	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.71 -1.2%		Hold
BRBY Burberry Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,129.50 +1.0%	GBX 1,080 ➝ GBX 1,080	Hold
BROS Dutch Bros	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.08 +4.4%		Outperform
BROS Dutch Bros	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew M. Charles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.08 +4.4%	$73.00	Buy
BROS Dutch Bros	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.08 +4.4%		Buy
BTDR Bitdeer Technologies Group	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.28 +3.5%		Market Perform
BYG Big Yellow Group	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 830.50 +2.3%	GBX 1,200 ➝ GBX 1,100	Buy
CAN Canaan	Target Lowered by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.44 +4.6%	$2.25 ➝ $1.30	Buy
CAR Avis Budget Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Percoco Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$152.80 +1.1%	$97.00 ➝ $99.00	Equal Weight
CASY Casey's General Stores	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Phillip Blee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$852.51 +0.0%		Outperform
CAVA CAVA Group	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.28 +2.8%	$95.00	Outperform
CAVA CAVA Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Bernstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.28 +2.8%	$70.00 ➝ $74.00	Equal Weight
CAVA CAVA Group	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Mullan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.28 +2.8%	$85.00 ➝ $92.00	Overweight
CAVA CAVA Group	Target Set by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.28 +2.8%	$100.00
CAVA CAVA Group	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Logan Reich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.28 +2.8%	$100.00 ➝ $105.00	Outperform
CAVA CAVA Group	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$80.28 +2.8%	$106.00	Buy
CAVA CAVA Group	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris O'Cull Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.28 +2.8%	$90.00 ➝ $105.00	Buy
CAVA CAVA Group	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew M. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.28 +2.8%	$100.00	Buy
CAVA CAVA Group	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Tarantino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.28 +2.8%	$88.00 ➝ $98.00	Outperform
CAVA CAVA Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Harbour Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.28 +2.8%	$85.00 ➝ $86.00	Equal Weight
CAVA CAVA Group	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarang Vora Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.28 +2.8%	$88.00 ➝ $92.00	Outperform
CAVA CAVA Group	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarang Vora Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$80.28 +2.8%	$92.00 ➝ $95.00	Outperform
CCI Crown Castle	Downgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Rosivach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$92.64 +0.3%		Outperform ➝ Peer Perform
CGY Calian Group	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$82.71 +2.3%	C$100.00	Buy
CHRW C.H. Robinson Worldwide	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephanie Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$180.64 +4.4%	$195.00 ➝ $200.00	Hold ➝ Buy
CHTR Charter Communications	Target Lowered by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$144.61 +1.5%	$328.00 ➝ $302.00	Buy
CI Cigna Group	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Hill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$283.36 -2.7%	$303.00 ➝ $302.00	Buy ➝ Hold
CI Cigna Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$283.36 -2.7%	$355.00 ➝ $361.00	Overweight
CM Canadian Imperial Bank of Commerce	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$157.09 +1.7%	C$136.00 ➝ C$143.00
CM Canadian Imperial Bank of Commerce	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$157.09 +1.7%	C$145.00 ➝ C$153.00	Hold
CNC Centene	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.28 -1.5%	$50.00 ➝ $58.00	Neutral
CNC Centene	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Hill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.28 -1.5%	$53.00 ➝ $80.00	Hold ➝ Buy
CNQ Canadian Natural Resources	Reiterated by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$48.79 -1.3%		Outperform
COST Costco Wholesale	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,074.01 -1.9%	$1,205.00 ➝ $1,275.00	Buy
CRC California Resources	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.89 -0.9%	$74.00 ➝ $78.00	Neutral ➝ Buy
CRNT Ceragon Networks	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Koontz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.48 -2.0%	$3.00	Buy
CRNT Ceragon Networks	Reiterated by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.48 -2.0%	$4.00	Buy
CURY Currys	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 142.50 -2.2%	GBX 155 ➝ GBX 155	Buy
CVS CVS Health	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$93.45 -0.8%	$102.00 ➝ $110.00	Outperform
CWAN Clearwater Analytics	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Heckmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.40 +0.1%	$24.55	Neutral
CWK Cranswick	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 5,460 -0.7%	GBX 6,100 ➝ GBX 6,100	Buy
CWK Cranswick	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 5,460 -0.7%	GBX 62 ➝ GBX 62	Buy
CYRX CryoPort	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Knight Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.07 +8.0%	$15.00 ➝ $17.00	Overweight
DAVE Dave	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gary Prestopino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$243.80 +2.0%	$290.00	Outperform
DCC DCC	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 6,145 +0.5%	GBX 6,500 ➝ GBX 6,500	Sector perform
DCC DCC	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 6,145 +0.5%	GBX 6,100 ➝ GBX 6,100	Buy
DCC DCC	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 6,145 +0.5%	GBX 5,500 ➝ GBX 6,000	Hold
DCCPF DCC	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$78.52		Hold
DELL Dell Technologies	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$243.00 +3.3%	$280.00	Outperform
DIV Diversified Royalty	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$4.78 +2.4%	C$4.75 ➝ C$5.50	Buy
Musk's shopping list: batteries ✓ solar ✓ data ✓ power ___ (Ad) Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity for $2.6 billion and Twitter for $44 billion. Now one small company makes the equipment his Colossus supercomputer - a million GPUs consuming nearly $1 billion a month in power - cannot run without. Analyst Dylan Jovine has identified the name and ticker. For investors who own shares before a potential move, the math could be significant. See the stock Musk's acquisition pattern points to next
DIV Diversified Royalty	Target Raised by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$4.78 +2.4%	C$4.25 ➝ C$4.70	Outperform
DKNG DraftKings	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.01 -2.1%	$43.00	Buy
DKS DICK'S Sporting Goods	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$218.80 +3.4%	$240.00 ➝ $255.00	Outperform
DND Dye & Durham	Target Lowered by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$2.93 +2.8%	C$5.00 ➝ C$4.00	Market Perform
DPLM Diploma	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 6,872.44 +0.5%	GBX 6,400 ➝ GBX 7,200	Buy
DPLM Diploma	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 6,872.44 +0.5%	GBX 5,700 ➝ GBX 5,700	Hold
DPLM Diploma	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 6,872.44 +0.5%	GBX 6,600 ➝ GBX 7,300	Outperform
DRTS Alpha Tau Medical	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.18 +4.7%	$15.00	Buy
DRUG Bright Minds Biosciences	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yasmeen Rahimi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.78 +11.1%	$190.00 ➝ $220.00	Overweight
DRVN Driven Brands	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.99 -1.8%		Outperform
DRVN Driven Brands	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.99 -1.8%	$11.00 ➝ $13.00	Neutral
DRVN Driven Brands	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.99 -1.8%	$20.00 ➝ $18.00	Outperform
DRVN Driven Brands	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.99 -1.8%	$18.00	Outperform
DRVN Driven Brands	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.99 -1.8%	$17.00 ➝ $16.00	Equal Weight
DRVN Driven Brands	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marvin Fong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.99 -1.8%	$21.00 ➝ $17.00	Buy
DRVN Driven Brands	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.99 -1.8%		Neutral
DVN Devon Energy	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.46 -2.5%	$60.00 ➝ $65.00	Buy
EBAY eBay	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$118.96 +4.1%	$95.00 ➝ $100.00	Market Perform
ECL Ecolab	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laurence Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$248.85 +1.3%	$352.00 ➝ $345.00	Buy
ECO Eco (Atlantic) Oil & Gas	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 65 +8.3%	GBX 125 ➝ GBX 125	Buy
EGHT 8X8	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.26 -6.2%	$2.75 ➝ $3.00	Buy
ELV Elevance Health	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Hill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$396.18 -1.5%	$363.00 ➝ $498.00	Hold ➝ Buy
ELV Elevance Health	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$396.18 -1.5%	$385.00 ➝ $435.00	Outperform
ENOG Energean	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 887 +0.1%	GBX 765 ➝ GBX 765	Hold
ENOG Energean	Reiterated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 887 +0.1%	GBX 950 ➝ GBX 950	Buy
ENPH Enphase Energy	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$53.15 +13.7%	$51.00 ➝ $57.00	Buy
EOG EOG Resources	Target Lowered by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bob Brackett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$141.71 -1.8%	$167.00 ➝ $155.00	Market Perform
EOG EOG Resources	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$141.71 -1.8%	$142.00 ➝ $147.00	Neutral
EPD Enterprise Products Partners	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Kad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.41 -1.0%	$42.00 ➝ $43.00	Underweight
EQB EQB	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$115.59 +1.0%	C$110.00 ➝ C$112.00
EQIX Equinix	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Osha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,065.06 +1.6%	$1,235.00	Buy
ESI Element Solutions	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$40.50 +2.6%		Outperform
ESNT Essentra	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 86.90 +6.0%	GBX 130 ➝ GBX 130	Buy
ETSY Etsy	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$60.82 +5.6%	$77.00 ➝ $72.00
ETSY Etsy	Target Set by	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$60.82 +5.6%	$76.00	Neutral ➝ Buy
EWG European Wealth Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 107.60 +0.7%	GBX 132 ➝ GBX 132	Buy
EXP Eagle Materials	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trey Grooms Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$199.70 -0.1%	$235.00 ➝ $225.00	Equal Weight
EXP Eagle Materials	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Codling Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$199.70 -0.1%	$208.00 ➝ $219.00	Sector Perform
EXP Eagle Materials	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$199.70 -0.1%	$200.00	Hold
EXPN Experian	Reiterated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,676 -1.3%	GBX 4,400 ➝ GBX 4,400	Buy
FANG Diamondback Energy	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$204.33 -1.7%	$225.00 ➝ $245.00	Buy
FFIV F5	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meta Marshall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$382.42 -0.3%	$340.00 ➝ $380.00	Equal Weight
FNV Franco-Nevada	Upgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derick Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$225.28 +1.1%	$292.00 ➝ $291.00	Hold ➝ Buy
FNV Franco-Nevada	Upgraded by	TD Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$225.28 +1.1%	$292.00 ➝ $291.00	Hold ➝ Buy
FNV Franco-Nevada	Upgraded by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$225.28 +1.1%	$291.00	Hold ➝ Buy
FORT Forterra	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 137.40 -1.7%	GBX 220 ➝ GBX 170	Hold
FORT Forterra	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 137.40 -1.7%	GBX 220 ➝ GBX 195	Outperform
FORT Forterra	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 137.40 -1.7%	GBX 204 ➝ GBX 204	Buy
FORT Forterra	Target Lowered by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 137.40 -1.7%	GBX 320 ➝ GBX 250	Buy
FOUR 4imprint Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,756 +2.4%	GBX 5,140 ➝ GBX 5,140	Buy
Trump's gold order: the announcement they won't put on the front page (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now
FUBO fuboTV	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.20 -0.1%	$15.00	Buy
GAP GAP	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Drbul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.31 +7.3%	$31.00 ➝ $28.00	Buy
GE GE Aerospace	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Herbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$300.11 +5.2%	$355.00 ➝ $355.00	Outperform
GILD Gilead Sciences	Upgraded by	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Okunewitch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$130.69 +0.1%	$165.00	Hold ➝ Buy
GLNG Golar LNG	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$55.46 -0.3%	$67.00	Buy
GOOG Alphabet	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Kelley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$384.90	$420.00
GOOG Alphabet	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$384.90		Overweight
GOOGL Alphabet	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$388.91 +0.3%	$427.00 ➝ $435.00	Overweight
GOOGL Alphabet	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$388.91 +0.3%	$450.00	Buy
GOOGL Alphabet	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Justin Patterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$388.91 +0.3%	$425.00	Overweight
GOOGL Alphabet	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Boone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$388.91 +0.3%	$515.00	Market Outperform
GOOGL Alphabet	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$388.91 +0.3%		Buy
GOOGL Alphabet	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Ju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$388.91 +0.3%		Neutral
GRMN Garmin	Target Raised by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$236.95 +3.6%	$320.00 ➝ $325.00	Strong-Buy
GRMN Garmin	Reiterated by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$236.95 +3.6%		Strong-Buy
HAL Halliburton	Target Raised by	Capital One Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$42.27 -1.7%	$41.00 ➝ $50.00	Overweight
HD Home Depot	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$310.66 +2.7%	$409.00 ➝ $390.00	Buy
HD Home Depot	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$420.00 ➝ $400.00	Overweight
HD Home Depot	Target Lowered by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$310.66 +2.7%	$415.00 ➝ $400.00	Outperform
HD Home Depot	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$310.66 +2.7%	$423.00 ➝ $396.00	Overweight
HD Home Depot	Target Lowered by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$310.66 +2.7%	$392.00 ➝ $310.00	Hold
HD Home Depot	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Bellinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$415.00 ➝ $385.00	Outperform
HD Home Depot	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Benedict Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$430.00 ➝ $380.00	Outperform
HD Home Depot	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$435.00 ➝ $410.00	Outperform
HD Home Depot	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Forbes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$425.00	Buy
HD Home Depot	Target Set by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$378.00
HD Home Depot	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$422.00 ➝ $421.00	Overweight
HD Home Depot	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$377.00 ➝ $340.00	Sector Perform
HD Home Depot	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Max Rakhlenko Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$450.00 ➝ $375.00	Buy
HD Home Depot	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zhihan Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$346.00	Market Perform
HD Home Depot	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zachary Fadem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$375.00 ➝ $360.00	Overweight
HD Home Depot	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$310.66 +2.7%	$450.00 ➝ $430.00	Buy
HFG Hilton Food Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 553.50 -0.2%	GBX 815 ➝ GBX 815	Buy
HSY Hershey	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Baumgartner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$190.71 -1.1%	$195.00 ➝ $185.00	Neutral
HUM Humana	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Hill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$304.64 -1.9%	$235.00 ➝ $441.00	Hold ➝ Buy
HUM Humana	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$304.64 -1.9%	$290.00 ➝ $335.00	Outperform
HUM Humana	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$304.64 -1.9%		Cautious ➝ Reduce
HUM Humana	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$304.64 -1.9%		Buy
HUM Humana	Downgraded by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$304.64 -1.9%		Peer Perform
HUM Humana	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Hill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$304.64 -1.9%		Buy ➝ Hold
HUM Humana	Upgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$304.64 -1.9%		Outperform
HUM Humana	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$304.64 -1.9%		Buy
HUM Humana	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$304.64 -1.9%		Outperform
HUM Humana	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$304.64 -1.9%		Neutral ➝ Overweight
IBRX ImmunityBio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.05 +3.7%	$15.00	Buy
ICE Intercontinental Exchange	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$151.61 -1.6%	$205.00	Buy
IFS Intercorp Financial Services	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yuri Fernandes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.62 +6.4%	$48.00 ➝ $56.00	Overweight
IGG IG Group	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,782.54 +2.3%	GBX 1,650 ➝ GBX 1,750	Buy
IGG IG Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,782.54 +2.3%	GBX 1,250 ➝ GBX 1,250	Buy
IGG IG Group	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,782.54 +2.3%	GBX 1,600 ➝ GBX 1,850	Outperform
From the man who predicted 2008 crash… (Ad) Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the biggest story of his 26-year career - an economic shift not seen since 1776. From the government taking stakes in Intel, Lithium Americas, and MP Materials, to sweeping political changes reshaping the economy, Stansberry argues a rare 'New 1776 Moment' is already underway. One Nobel Prize winner calls it a dividing line for all of society. His presentation covers the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. Watch Porter Stansberry's full briefing and learn how to prepare now
IHP IntegraFin	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 333 -1.3%	GBX 360 ➝ GBX 360	Hold
INTS Intensity Therapeutics	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.63 +0.9%		Speculative Buy
IPX Impax Asset Management Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 102.80 -0.6%	GBX 170 ➝ GBX 170	Buy
ITH Ithaca Energy	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 274.60 -3.9%	GBX 210 ➝ GBX 210	Buy
ITRI Itron	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tommy Moll Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.35 +4.3%	$130.00	Overweight
JD JD Sports Fashion	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 75.52 +2.8%	GBX 86 ➝ GBX 83	Neutral
KEYS Keysight Technologies	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.13 -0.6%	$320.00 ➝ $387.00	Overweight
KEYS Keysight Technologies	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.13 -0.6%	$300.00 ➝ $390.00	Overweight
KEYS Keysight Technologies	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Eastman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.13 -0.6%	$375.00 ➝ $385.00	Outperform
KEYS Keysight Technologies	Target Set by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mehdi Hosseini Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.13 -0.6%	$425.00
KEYS Keysight Technologies	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Delaney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.13 -0.6%		Buy
KEYS Keysight Technologies	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meta Marshall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.13 -0.6%	$305.00 ➝ $350.00	Equal Weight
KEYS Keysight Technologies	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Spinola Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$342.13 -0.6%	$340.00 ➝ $420.00	Buy
KGH Knights Group	Reiterated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 193.75 +12.0%	GBX 220 ➝ GBX 220	Buy
KLAC KLA	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stacy Rasgon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,829.47 +5.1%	$1,875.00 ➝ $1,975.00	Outperform
KLR Keller Group	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,334 +3.1%	GBX 2,350 ➝ GBX 2,550	Buy
KRMN Karman	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Leshock Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$65.53 +2.1%	$122.00 ➝ $100.00	Overweight
LMRI Lumexa Imaging	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.40 +5.7%	$15.00 ➝ $9.00	Overweight
LORD Lords Group Trading	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 16.50 -4.3%	GBX 65 ➝ GBX 65	Buy
LORD Lords Group Trading	Reiterated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 16.50 -4.3%	GBX 19 ➝ GBX 19	Hold
LOW Lowe's Companies	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Baker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$221.25 +1.3%	$275.00	Neutral
LOW Lowe's Companies	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$221.25 +1.3%	$280.00
LUCE Luceco	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 270.37 +12.7%	GBX 225 ➝ GBX 260	Buy
LUNR Intuitive Machines	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edison Yu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.67 +3.7%	$34.00	Buy
LUXE LuxExperience B.V.	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Oliver Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.36 +7.1%	$12.00 ➝ $8.00	Buy
MAB1 Mortgage Advice Bureau	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 525 -2.6%	GBX 1,150 ➝ GBX 1,150	Buy
MAMA Mama's Creations	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Holland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.44 +0.4%	$25.00	Buy
MANH Manhattan Associates	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Clark Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.08 +1.2%	$200.00	Buy
MANH Manhattan Associates	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$137.08 +1.2%	$200.00
MDB MongoDB	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Power Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$329.14 -1.7%	$260.00 ➝ $335.00	Neutral
META Meta Platforms	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$605.06 +0.4%	$770.00 ➝ $765.00	Overweight
MKS Marks and Spencer Group	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 348.50 +6.6%		House Stock
MP MP Materials	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Summerville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$56.29 +2.5%	$82.00	Buy
MPLX Mplx	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Kad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.53 -0.1%	$62.00 ➝ $60.00	Equal Weight
MRKR Marker Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.41 +1.4%		Buy
MRVL Marvell Technology	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$186.80 +6.0%	$135.00 ➝ $195.00	Overweight
MRVL Marvell Technology	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Schafer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$186.80 +6.0%	$170.00 ➝ $200.00	Outperform
MT ArcelorMittal	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$63.06 +6.6%		Buy
NA National Bank of Canada	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$209.80 +1.3%	C$172.00 ➝ C$188.00
NA National Bank of Canada	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$209.80 +1.3%	C$190.00 ➝ C$200.00	Hold
NJR NewJersey Resources	Target Set by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristina Ruggeri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$57.47 -1.2%	$63.00
NOG Northern Oil and Gas	Downgraded by	Johnson Rice Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Meade Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.15 -3.0%	$36.00	Accumulate ➝ Hold
NTAP NetApp	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wamsi Mohan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$118.97 -1.3%	$118.00 ➝ $125.00	Neutral
NU NU	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thiago Batista Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.79 +4.0%	$18.10 ➝ $16.90	Buy
NVDA NVIDIA	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$223.47 +1.3%		Buy
NWL Newell Brands	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dara Mohsenian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.53 -0.6%	$4.00 ➝ $3.50	Equal Weight ➝ Underweight
OCS Oculis	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.91 -0.2%	$75.00	Buy
OKTA Okta	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$89.04 +3.9%		Negative ➝ Positive
ORLA Orla Mining	Upgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.31 +1.2%		Hold ➝ Buy
ORLA Orla Mining	Upgraded by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.31 +1.2%		Hold ➝ Buy
OUTKY Outokumpu	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.16		Neutral
OVV Ovintiv	Upgraded by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Fisk Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.66 -2.0%		Outperform ➝ Buy
OVV Ovintiv	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Fisk Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.66 -2.0%	$67.00 ➝ $70.00	Sector Outperform
PAA Plains All American Pipeline	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Kad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.33 -1.2%	$23.00 ➝ $25.00	Equal Weight
PAGP Plains GP	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Kad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.12 -0.8%	$24.00 ➝ $26.00	Equal Weight
PANW Palo Alto Networks	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$246.66 +2.7%	$285.00	Overweight
PANW Palo Alto Networks	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Borg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.66 +2.7%	$185.00 ➝ $275.00	Buy
PANW Palo Alto Networks	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hamza Fodderwala Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.66 +2.7%	$223.00 ➝ $253.00	Overweight
PANW Palo Alto Networks	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$246.66 +2.7%	$200.00 ➝ $270.00	Outperform
PBL Pollard Banknote	Target Lowered by	ATB Cormark Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$16.10 -0.9%	C$41.00 ➝ C$32.00	Outperform
PDLB Ponce Financial Group	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.53 +4.7%	$24.00
PGR Progressive	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Zaremski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$202.79 0.0%	$220.00	Market Perform
PGR Progressive	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Shanker Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$202.79 0.0%		Buy
PHR Phreesia	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stan Berenshteyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.84 -3.7%	$15.00 ➝ $9.00	Overweight ➝ Equal Weight
PKG Packaging Corporation of America	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anojja Shah Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$212.99 +4.8%	$232.00 ➝ $248.00	Neutral ➝ Buy
PLNT Planet Fitness	Target Lowered by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Kelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$50.26 -2.7%	$109.00 ➝ $64.00	Buy
PODD Insulet	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Lichtman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$156.59 +1.3%		Outperform
PRAX Praxis Precision Medicines	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kambiz Yazdi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$335.61 +4.7%	$843.00	Buy
PSA Public Storage	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$302.83 +1.8%	$350.00 ➝ $355.00	Buy
PTEC Playtech	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 365 +0.5%	GBX 405 ➝ GBX 405	Hold
PURR Hyperliquid Strategies	Target Raised by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.12 +4.2%	$8.45 ➝ $9.75	Buy
PYPL PayPal	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.38 +1.3%	$42.00	Hold
QUIK QuickLogic	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Neil Young Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.46 +14.2%	$22.00	Buy
RAL Ralliant	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Giordano Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.62 +1.7%	$55.00 ➝ $70.00	Buy
RANI Rani Therapeutics	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Nash Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.09 +23.2%	$5.00	Buy
RBRK Rubrik	Upgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Param Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.42 +3.3%	$85.00	Market Perform ➝ Outperform
RDNT RadNet	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.21 +1.6%	$70.00 ➝ $65.00	Overweight
RITM Rithm Capital	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.28 +3.1%		Outperform
RITM Rithm Capital	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trevor Cranston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.28 +3.1%	$12.50 ➝ $13.50	Market Outperform
RLAY Relay Therapeutics	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Silvan Turkcan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.02 +7.9%	$19.00 ➝ $21.00	Market Outperform
RLAY Relay Therapeutics	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.02 +7.9%		Outperform
RLAY Relay Therapeutics	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Etzer Darout Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.02 +7.9%	$21.00 ➝ $27.00	Overweight
RS1 RS Group	Reiterated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 690 +14.9%	GBX 675 ➝ GBX 675	Buy
RSI Rush Street Interactive	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$27.70 -1.1%	$27.00 ➝ $30.00	Market Outperform
RSI Rush Street Interactive	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$27.70 -1.1%		Outperform
RY Royal Bank of Canada	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$257.34 +1.9%	C$260.00 ➝ C$270.00	Buy
RY Royal Bank of Canada	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$257.34 +1.9%	C$226.00 ➝ C$232.00
S SentinelOne	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.95 +1.7%	$16.00 ➝ $19.00	Equal Weight
SABS SAB Biotherapeutics	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Roger Song Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.68 +3.7%	$11.00	Buy
SAIL SailPoint	Initiated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.98 +3.5%	$19.00	Buy
SDXAY Sodexo	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.70 -0.6%		Neutral
SG Sweetgreen	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Bittner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.03 +4.6%	$9.00 ➝ $10.00	Outperform
SGHC Super Group (SGHC)	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.74 -1.0%		Outperform
SGHC Super Group (SGHC)	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jordan Bender Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.74 -1.0%	$16.00 ➝ $17.00	Market Outperform
SHAK Shake Shack	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$63.45 -1.0%		Neutral
SJM J. M. Smucker	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steve Powers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$100.39 -2.6%	$95.00	Hold
SKIN Beauty Health	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Kelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.68 +2.3%	$2.50 ➝ $2.00	Buy
SM SM Energy	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Freeman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.77 +1.3%	$55.00	Underperform ➝ Outperform
SMGZY Smiths Group	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$33.57 +0.9%		Hold
SMTC Semtech	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Rolland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$141.85 +5.2%	$110.00 ➝ $170.00	Positive
SNOW Snowflake	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eric Heath Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$166.81 -1.6%		Overweight
SPGI S&P Global	Target Lowered by	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$416.72 +1.5%	$490.00 ➝ $485.00	Outperform
SRAD Stelrad Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 135.60 +0.4%	GBX 190 ➝ GBX 190	Buy
SSAAY SSAB	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.82 +3.6%		Buy
SSPG SSP Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 165.80 +2.2%	GBX 262 ➝ GBX 262	Buy
SUUN PowerBank	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$0.71 +13.4%		Buy
SYNA Synaptics	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$129.82 +5.0%	$125.00 ➝ $180.00	Buy
SZGPY Salzgitter	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.40		Neutral
T AT&T	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Atkin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.93 -0.2%	$31.00	Outperform
TARA Protara Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.76 +9.7%		Overweight
TARA Protara Therapeutics	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Leland Gershell Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.76 +9.7%	$25.00 ➝ $28.00	Outperform
TARA Protara Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.76 +9.7%		Buy
TARA Protara Therapeutics	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.76 +9.7%		Buy
TD Toronto-Dominion Bank	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$150.47 +1.4%	C$134.00 ➝ C$142.00
TD Toronto-Dominion Bank	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$150.47 +1.4%	C$149.00 ➝ C$158.00	Buy
TGT Target	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Heinbockel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$122.91 -3.4%	$140.00	Buy
TGT Target	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$122.91 -3.4%	$130.00
TIGO Millicom International Cellular	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marcelo Santos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$84.11 +3.9%	$86.00 ➝ $100.00	Overweight
TNK Teekay Tankers	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Hoexter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$78.95 +3.9%	$69.00 ➝ $75.00	Underperform
TRAW Traws Pharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.62 +1.9%	$8.00	Buy
TROX Tronox	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.95 +3.4%	$10.00
TRVI Trevi Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Serge Belanger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.88 +4.8%	$23.00	Buy
TTAN ServiceTitan	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Altmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.78 +0.5%	$105.00 ➝ $90.00	Buy
TTMI TTM Technologies	Reiterated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$169.36 +4.9%		Buy
UEC Uranium Energy	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.75 +7.1%	$26.75	Buy
UHS Universal Health Services	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$164.40 -1.2%	$235.00 ➝ $205.00	Neutral
UNH UnitedHealth Group	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$383.30 -1.5%	$410.00 ➝ $440.00	Outperform
VG Venture Global	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.07 -4.8%	$16.00	Outperform
VGZ Vista Gold	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.21 +4.7%	$4.50	Buy
VIC Victorian Plumbing Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 75.70 +1.1%	GBX 80 ➝ GBX 80	Hold
VRT Vertiv	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Elias Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$315.44 -2.2%	$347.00 ➝ $387.00	Buy
W Wayfair	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Forbes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.67 +12.7%	$100.00	Buy
WAY Waystar	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glen Santangelo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.21 -2.0%	$36.00 ➝ $25.00	Overweight
WBI WBI	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Kad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.59 -0.3%	$34.00 ➝ $38.00	Overweight
WDAY Workday	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$126.61 -2.1%	$200.00 ➝ $160.00	Overweight
WHD Cactus	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Gengaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.04 +2.0%	$59.00 ➝ $66.00	Buy
WMB Williams Companies	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Kad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$77.94 -1.8%	$90.00 ➝ $98.00	Overweight
WVE WAVE Life Sciences	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Burnett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.19 +0.8%	$13.00 ➝ $14.00	Overweight
XIFR XPLR Infrastructure	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Kad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.29 +2.2%	$11.00 ➝ $12.00	Underweight
XPOF Xponential Fitness	Upgraded by	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.39 +11.6%	$8.00	Market Perform ➝ Outperform
ZGN Ermenegildo Zegna	Upgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Oliver Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.39 +6.9%	$13.00 ➝ $15.00	Hold ➝ Buy
ZM Zoom Communications	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$99.42 +2.1%		Market Perform
ZS Zscaler	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$174.45 -0.5%		Overweight
ZS Zscaler	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$174.45 -0.5%		Buy
ZTO ZTO Express (Cayman)	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.16 -1.7%	$30.10	Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 07:13 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings